Publications by authors named "Nauman Hussain"
Background: Peripherally administered vasopressor infusions are used to support critically ill patients. The Intensive Care Society recently published guidelines supporting their use. Preliminary evidence suggests variability in peripheral vasopressor infusion use.
View Article and Find Full Text PDFIntroduction And Importance: Meniscal cysts, while infrequent with a prevalence of 1 %-8 %, may result in considerable knee discomfort and functional limitations. The cysts are categorized according to their position in relation through the meniscus, labeled as either intrameniscal or parameniscal. Although parameniscal cysts are often small and asymptomatic, they may expand and become painful with time.
View Article and Find Full Text PDFBackground: Venous thromboembolism (VTE) is a feared complication of joint arthroplasty, leading to recent clinical practice guidelines aimed at VTE prevention and prophylaxis. However, limited studies have examined national changes in practice regarding chemoprophylaxis and the resultant changes in VTE rates. The purpose of this study was to identify: (1) the temporal trends in thrombotic complications; and (2) changes in chemoprophylaxis utilization in patients undergoing elective total knee arthroplasty (TKA).
View Article and Find Full Text PDFArticle Synopsis
- Obesity negatively affects outcomes of total hip arthroplasty (THA), prompting surgeons to set body mass index limits and recommend preoperative weight loss for patients.
- A study analyzed THA patients from 2013-2020 to see if losing over 10% of body weight before surgery improved their postoperative results, adjusting for various patient factors.
- Findings showed that significant preoperative weight loss led to longer hospital stays and higher rates of complications for both general and obese patients, indicating that rapid weight loss may not be beneficial and could worsen outcomes.
A giant cell tumour (GCT) is a locally invasive benign tumour of bone in young adults. Treatment includes surgical resection as first-line or denosumab pharmacotherapy in inoperable patients. However, surgical resection of distal radius GCT has produced debatable functional outcomes.
View Article and Find Full Text PDFBackground: Denosumab has been approved by Food and Drug Authority in 2013 for use in surgically unresectable Giant cell tumor (GCT) to achieve resectable tumor margins. The aim of this study is to investigate the functional outcome and surgical convenience with the use of neoadjuvant denosumab before resection and reconstruction in Campanacci grade III GCT.
Methods: We retrospectively reviewed 70 cases of Campanacci grade III GCT receiving resection and reconstruction between January 2014 and December 2019.